← Back to Search

GPS clinical intervention for Dementia

N/A

Waitlist Available

Research Sponsored by CHU de Quebec-Universite Laval

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months prior to the start of the intervention and in the 12 months afterwards

Awards & highlights

Study Summary

This trial tests a care model that aims to reduce polymedication and inappropriate medications for seniors undergoing cognitive assessment or suffering from major neurocognitive disorder, while maintaining their cognitive health, quality of life, and autonomy.

Eligible Conditions

Dementia

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months prior to the start of the intervention and in the 12 months afterwards

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months prior to the start of the intervention and in the 12 months afterwards

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months prior to the start of the intervention and in the 12 months afterwards for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in number of prescribed medications

Secondary outcome measures

Change in treatment burden

Other outcome measures

Change in number of emergency room visits

Change in number of hospitalizations

Change in quality of life

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Exposed FMGs to GPS interventionExperimental Treatment1 Intervention

Patients who are followed by FMGs exposed to the GPS intervention. They will receive the GPS intervention.

Group II: Non exposed FMGs to GPS interventionActive Control1 Intervention

Patients who are part of the FMGs not exposed to the GPS intervention. They will receive the usual care and services.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

CHU de Quebec-Universite LavalLead Sponsor

167 Previous Clinical Trials

106,757 Total Patients Enrolled

1 Trials studying Dementia

44 Patients Enrolled for Dementia

CISSS de Chaudière-AppalachesOTHER_GOV

6 Previous Clinical Trials

15,279 Total Patients Enrolled

CIUSSS du Nord-de-l'Île-de-MontréalUNKNOWN

2 Previous Clinical Trials

272 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are enrolled in this research endeavor?

"Affirmative. Clinicaltrials.gov has the latest updates on this ongoing medical trial, first posted in September 2021 and last modified in January 2022. The study is currently enrolling 400 patients from 2 different healthcare facilities."

Answered by AI

Are there any open opportunities for participants in this clinical trial?

"Affirmative. According to information on clinicaltrials.gov, this medical trial that was initially announced on September 27th 2021 is still actively recruiting patients. A total of 400 individuals are sought from two separate medical facilities."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders

Dre Edeltraut Kröger 2021. "GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04889794.